L B Heifets - JoVE Visualize

Showing results (31-40 of 43) with videos related to

Pageof 5

Sort By:

Antimicrobial Agents and Chemotherapy|October 1, 1985

Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsL B Heifets, M D Iseman, P J Lindholm-Levy, et al.

The American Review of Respiratory Disease|December 1, 1985

Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulareV K Perumal, P R Gangadharam, L B Heifets, et al.

The American Review of Respiratory Disease|December 1, 1986

Pyrazinamide is not active in vitro against Mycobacterium avium complexL B Heifets, M D Iseman, A J Crowle, et al.

The American Review of Respiratory Disease|October 1, 1989

Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in TaiwanC H Chen, J F Shih, P J Lindholm-Levy, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1985

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methodsL B Heifets, M D Iseman, J L Cook, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000

Mycobacterium terrae: case reports, literature review, and in vitro antibiotic susceptibility testingD S Smith, P Lindholm-Levy, G A Huitt, et al.

The American Review of Respiratory Disease|February 1, 1987

Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testingC R Horsburgh, U G Mason, L B Heifets, et al.

Antimicrobial Agents and Chemotherapy|July 14, 1998

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosisD L Williams, L Spring, L Collins, et al.

Journal of Clinical Microbiology|September 1, 1993

Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolatesS H Siddiqi, L B Heifets, M H Cynamon, et al.

Annals of Internal Medicine|December 15, 1994

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.

Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:

Pageof 5

Antimicrobial Agents and Chemotherapy|October 1, 1985

Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsL B Heifets, M D Iseman, P J Lindholm-Levy, et al.

The American Review of Respiratory Disease|December 1, 1985

Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulareV K Perumal, P R Gangadharam, L B Heifets, et al.

The American Review of Respiratory Disease|December 1, 1986

Pyrazinamide is not active in vitro against Mycobacterium avium complexL B Heifets, M D Iseman, A J Crowle, et al.

The American Review of Respiratory Disease|October 1, 1989

Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in TaiwanC H Chen, J F Shih, P J Lindholm-Levy, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1985

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methodsL B Heifets, M D Iseman, J L Cook, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000

Mycobacterium terrae: case reports, literature review, and in vitro antibiotic susceptibility testingD S Smith, P Lindholm-Levy, G A Huitt, et al.

The American Review of Respiratory Disease|February 1, 1987

Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testingC R Horsburgh, U G Mason, L B Heifets, et al.

Antimicrobial Agents and Chemotherapy|July 14, 1998

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosisD L Williams, L Spring, L Collins, et al.

Journal of Clinical Microbiology|September 1, 1993

Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolatesS H Siddiqi, L B Heifets, M H Cynamon, et al.

Annals of Internal Medicine|December 15, 1994

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.

Pageof 5